SCHEDULE: Balyasny Entities Report Zero Ownership in Rallybio

Balyasny Asset Management L.P. and affiliated entities have filed a Schedule 13G amendment, reporting zero shares beneficially owned in Rallybio Corp.

Summary

• Balyasny Asset Management L.P. and its associated entities (BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny) have filed an amendment to their Schedule 13G.
• The filing indicates that these entities collectively hold 0 shares of Rallybio Corp. common stock.
• This represents 0.0% of the class of securities outstanding.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the complete absence of beneficial ownership, indicating a lack of investment or a divestment by the reporting persons.

Negatives

• The reporting persons, Balyasny Asset Management L.P. and its affiliates, hold zero shares of Rallybio Corp. common stock.
• This indicates no current beneficial ownership or investment in the company by these entities.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding future investments or strategies of the reporting persons concerning Rallybio Corp.

Management Comments

• The reporting persons certify that, to the best of their knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing typically indicates a passive investment stake of 5% or more. The complete absence of ownership reported here by a significant asset manager suggests a lack of current interest or a recent divestment in Rallybio Corp., which could be interpreted negatively by the market.

Stakeholder Impact

• Shareholders may view the lack of investment from a known asset manager as a negative signal, potentially impacting share price.

Key Dates

Recommendation

The filing indicates zero beneficial ownership by Balyasny Asset Management and its affiliates, suggesting no current investment or strategic interest. This lack of positive news or investment from a significant entity warrants a neutral 'hold' stance, pending further developments or clarification.

Keywords

Rallybio Corp, Schedule 13G, Balyasny Asset Management, Beneficial Ownership, Securities Exchange Act